Dr. Yaser Alkhatib Consultant Medical Oncology
Years of Experience : 8
Nationality : United States of America
Languages Known : Arabic, English
Book AppointmentBiography
Dr. Yaser Alkhatib is a Hematologist and Medical Oncologist holding the American Board of Hematology and American Board of Oncology, with a distinguished career spanning academic medicine, clinical practice, and medical education. He graduated from University of Jordan – Faculty of Medicine and then completed Internal Medicine and Hematology/Oncology training from Henry Ford Hospital/Wayne State University, where he also served as a chief fellow. Dr. Yaser has an extensive experience at top-tier institutions including world-renowned MD Anderson Cancer Center, and Houston Methodist, the leading hospital in the state of Texas, where he has developed a robust expertise in managing a wide spectrum of hematologic and oncologic disorders. Throughout his career, Dr. Yaser has held multiple academic and administrative roles, including Assistant Professor in the Departments of General Oncology and Lymphoma & Myeloma at MD Anderson, where he also served on the steering committee for the Texas Statewide Lymphoma Grand Rounds. He is a sought-after mentor and educator, having contributed significantly to fellowship and residency training programs, and has been recognized with prestigious awards such as the MD Anderson – Vicente Valero LBJ Clinician Educator of the Year Award and the Fellow of the Year Award. Dr. Yaser is an accomplished researcher with numerous peer-reviewed publications and national conference presentations. His research interests include lymphoma, and clinical outcomes in hematologic malignancies. Combining clinical excellence, academic leadership, and a patient-centered approach, Dr. Yaser continues to make impactful contributions to the field of hematology and oncology.
Awards & Achievements
- Chief Fellow
- Fellow of the year
- MD Anderson – Vicente Valero LBJ Clinician Educator of the Year
Research & Publications
- Successful posthospitalization oncology workflow implementing LACE+ score to stratify and reduce readmissions within a safety-net hospital
- Outcomes of Patients with Thrombocytopenia Evaluated at Hematology Subspecialty Clinics
- Idiopathic erythrocytosis in dialysis patients: a case report and literature review
- Sideroblastic anemia secondary to zinc toxicity
- Lymphadenopathy in a patient with chronic myeloid leukemia
- P-selectin expression assay in a repeatedly serotonin-release assay-negative patient with heparin-induced thrombocytopenia
- The role of tyrosine kinase inhibitor "Lapatinib" in pulmonary hypertension
- Clinical impact of metformin in diabetic diffuse large B-cell lymphoma patients: a case-control study
- Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature
- Spontaneous intestinal hematoma associated with neurofibromatosis type-1
Expertise
- Advanced lymphoma, including refractory case management
- Multiple myeloma: frontline and relapse care
- Leukemia and MDS diagnosis and treatment
- Benign hematologic and myeloproliferative disorders
- Multidisciplinary solid tumor care
Membership
- American Society of Hematology
- American Society of Hematology
- Society of Hematologic Oncology
- Texas Medical Association
- Harris County Medical Society
Blogs
Detecting Early Symptoms of Breast Cancer: A Guide for Women
Read more
Kidney Cancer – Symptoms, Causes & Treatment
Read more
Cervical Cancer – Symptoms, Causes & Treatment
Read more
